ATE103931T1 - Polypeptide aus vipergift und deren genexpression. - Google Patents

Polypeptide aus vipergift und deren genexpression.

Info

Publication number
ATE103931T1
ATE103931T1 AT89200967T AT89200967T ATE103931T1 AT E103931 T1 ATE103931 T1 AT E103931T1 AT 89200967 T AT89200967 T AT 89200967T AT 89200967 T AT89200967 T AT 89200967T AT E103931 T1 ATE103931 T1 AT E103931T1
Authority
AT
Austria
Prior art keywords
polypeptides
amino acid
gene expression
viper venom
cys
Prior art date
Application number
AT89200967T
Other languages
English (en)
Inventor
Paul A Friedman
Mark A Polokoff
Robert J Gould
Gerard H Bencen
John W Jacobs
Victor M Garsky
Zhong-Ru Gan
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE103931T1 publication Critical patent/ATE103931T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT89200967T 1988-04-22 1989-04-17 Polypeptide aus vipergift und deren genexpression. ATE103931T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18464988A 1988-04-22 1988-04-22
US18465388A 1988-04-22 1988-04-22
US30375789A 1989-02-01 1989-02-01
EP89200967A EP0338634B1 (de) 1988-04-22 1989-04-17 Polypeptide aus Vipergift und deren Genexpression

Publications (1)

Publication Number Publication Date
ATE103931T1 true ATE103931T1 (de) 1994-04-15

Family

ID=27391870

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89200967T ATE103931T1 (de) 1988-04-22 1989-04-17 Polypeptide aus vipergift und deren genexpression.

Country Status (14)

Country Link
EP (1) EP0338634B1 (de)
JP (1) JPH02138298A (de)
KR (1) KR900016261A (de)
CN (1) CN1039441A (de)
AT (1) ATE103931T1 (de)
AU (1) AU627724B2 (de)
DE (1) DE68914316T2 (de)
DK (1) DK192189A (de)
ES (1) ES2063113T3 (de)
FI (1) FI891916A (de)
IL (1) IL89938A0 (de)
NO (1) NO891662L (de)
NZ (1) NZ228710A (de)
PT (1) PT90321B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989005150A1 (en) * 1987-12-10 1989-06-15 La Jolla Cancer Research Foundation Conformationally stabilized cell adhesion peptides
US5827821A (en) 1987-12-10 1998-10-27 The Burnham Institute Conformationally stabilized cell adhesion peptides
US5196403A (en) * 1989-01-27 1993-03-23 Biogen, Inc. Method of inhibiting platelet activation
US5182260A (en) * 1989-01-27 1993-01-26 Biogen, Inc. Dna sequences encoding snake venom inhibitors of platelet activation processes for producing those inhibitors and compositions using them
EP0382451A3 (de) * 1989-02-07 1991-05-29 Merck & Co. Inc. Polypeptide und deren Varianten aus dem Gift von Schlangen
EP0382538A3 (de) * 1989-02-09 1991-10-23 Merck & Co. Inc. Synthese von Polypeptiden
US5384309A (en) * 1989-07-17 1995-01-24 Genentech, Inc. Cyclized peptides and their use as platelet aggregation inhibitors
WO1991011458A1 (en) * 1990-02-02 1991-08-08 Genentech, Inc. CYCLIC PEPTIDES CONTAINING Arg-Gly-Asp FLANKED BY PROLINE
US5227469A (en) * 1990-02-14 1993-07-13 Genentech, Inc. Platelet aggregation inhibitors from the leech
DK0527798T3 (da) * 1990-04-06 1997-12-15 Jolla Cancer Res Found Fremgangsmåde og sammensætning til behandling af thrombose
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5612311A (en) * 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5648330A (en) * 1990-04-06 1997-07-15 La Jolla Cancer Research Foundation Method and composition for treating vascular graft occlusion
US5179082A (en) * 1990-11-13 1993-01-12 Merck & Co., Inc. Method for blocking platelet adhesion to collagen
US5342830A (en) * 1990-11-16 1994-08-30 Cor Therapeutics, Inc. Antithrombosis agents
US5242810A (en) * 1990-12-07 1993-09-07 Biogen, Inc. Bifunctional inhibitors of thrombin and platelet activation
JPH06509551A (ja) * 1991-04-05 1994-10-27 ジェネンテク,インコーポレイテッド Gp II↓bIII↓aに対する高い特異性を有する血小板凝集阻害剤
US5380646A (en) * 1992-10-19 1995-01-10 Temple University Of The Commonwealth System Of Higher Education Thrombus detection using radiolabelled disintegrins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683291A (en) * 1985-10-28 1987-07-28 Scripps Clinic And Research Foundation Platelet binding inhibitors
DE3886175T2 (de) * 1987-11-18 1994-04-07 Univ Temple Trigramin, ein Polypeptid, das die Aggregation der Blutplättchen hemmt.

Also Published As

Publication number Publication date
IL89938A0 (en) 1989-12-15
EP0338634A3 (de) 1991-05-29
DE68914316T2 (de) 1994-09-08
DK192189A (da) 1989-10-23
PT90321A (pt) 1989-11-10
FI891916A0 (fi) 1989-04-21
PT90321B (pt) 1994-08-31
AU3329989A (en) 1990-02-15
NO891662L (no) 1989-10-23
KR900016261A (ko) 1990-11-13
AU627724B2 (en) 1992-09-03
DK192189D0 (da) 1989-04-20
NO891662D0 (no) 1989-04-21
CN1039441A (zh) 1990-02-07
ES2063113T3 (es) 1995-01-01
JPH02138298A (ja) 1990-05-28
DE68914316D1 (de) 1994-05-11
FI891916A (fi) 1989-10-23
EP0338634A2 (de) 1989-10-25
EP0338634B1 (de) 1994-04-06
NZ228710A (en) 1992-10-28

Similar Documents

Publication Publication Date Title
ATE103931T1 (de) Polypeptide aus vipergift und deren genexpression.
DE69232725T2 (de) Synthetische dna-sequenz mit verstärkter isektizider aktivität in mais
ATE353362T1 (de) Neuartige ctla4/cd28 liganden und deren anwendungen
CA2168429A1 (en) Expression of fusion polypeptides transported out of cytoplasm without leader sequences
PT85977A (en) Process for the preparation of human apolipoprotein ai and their variant forms by recombinant dna methods
DE69334350D1 (de) P- Selectin Ligandenprotein
EP0458959A4 (en) Novel platelet-derived growth factor b chain analogs and method for homogeneous production thereof
DE3686579D1 (en) Prokaryotisches expressionssystem.
EP0422125A4 (en) Platelet blocking peptides
NO895028D0 (no) Ny chimerisk transformerende vekstfaktor-beta.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
ATE102994T1 (de) Verfahren zur herstellung von proteinen.
ATE109827T1 (de) Verfahren zur herstellung von peptiden, dazu zu verwendendes rekombinantes plasmid und mit diesem plasmid transformierte myelomzellen.
DE59108261D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
EP0723016A3 (de) Leukocyten-aktivierender Faktor
CA2067334A1 (en) Recombinant production of lactoperoxidase
KR950032619A (ko) 변형된 인간 적혈구 성장 촉진 인자 유전자 및 그의 발현벡터

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee